Skip to content

Efficacy and safety of acupuncture in treating Nonarteritis anterior ischemic optic neuropathy

Efficacy of traditional Chinese medicine in treating Nonarteritis anterior ischemic optic neuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080189
Enrollment
Unknown
Registered
2024-01-23
Start date
2023-06-13
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonarteritis anterior ischemic optic neuropathy

Interventions

Sponsors

Eye Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age of onset: between 50-80 years, both sexes. 2. Duration of the disease: 1-5 months after the onset of the disease. 3. Clinical symptoms: onset of painless visual loss in one or both eyes; sudden onset of visual loss and/or visual field defects; optic disc edema with or without hard exudation from the hemorrhagic papillary bundles along the disc; changes in the optic disc corresponding to the visual field defects; and the exclusion of other ocular or systemic disorders that may contribute to the above clinical manifestations. 4. A crowded disc in the contralateral eye supports the diagnosis of NAION in the affected eye. 5. If the patient has a sequential onset in both eyes, and the onset of both eyes is within 1-5 months, the posterior eye will be included in the group. 6. systemic diseases such as blood sugar and blood pressure are well controlled.

Exclusion criteria

Exclusion criteria: 1. Ex-arterial inflammatory anterior ischemic optic neuropathy (no pain, no abnormalities in CRP or ESR). 2. Use of hormone therapy within one week before enrollment. 3. Other ocular diseases or refractive errors exceeding ±6.00 DS. 4. Patients with recurrent episodes of NAION in one eye. 5. Patients who refused to sign the informed consent form or withdrew their informed consent during follow-up.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;

Secondary

MeasureTime frame
Vision Field;Optical Coherence Tomography;Best corrected visual acuity;Patients with a worst visual acuity of less than 0.3 at onset improved the incidence of 3 rows or more;

Countries

China

Contacts

Public ContactWang Ying

Eye Hospital,China Academy of Chinese Medical Sciences

wangyingtcm@163.com+86 135 8151 5068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026